Dr. Eric Topol’s longevity work identified daily habits to follow in a study of “super agers” who are healthy at ages 85 and above."I am taking my own advice," says Dr. Topol, a 70-year-old cardiologist.He shares the tips that he follows: 🔗 https://t.co/4fHKI34FdQ https://t.co/jUsHt3GunT ...

Outperforming is rare. Outlasting is available to everyone. ...

Dr. Eric Topol’s longevity work identified daily habits to follow in a study of “super agers” who are healthy at ages 85 and above."I am taking my own advice," says Dr. Topol, a 70-year-old cardiologist.He shares the tips that he follows: 🔗 https://t.co/ORqrQxhYYl https://t.co/6xLX56GzU0 ...

Dr. Eric Topol’s longevity work identified daily habits to follow in a study of “super agers” who are healthy at ages 85 and above."I am taking my own advice," says Dr. Eric Topol, a 70-year-old cardiologist.He shares the tips that he follows: 🔗 https://t.co/I0CWR7gPyv https://t.co/ZWDlJdPatK ...

Company Overview - EUDA Health Holdings Limited is a leading non-invasive healthcare provider based in Singapore, focusing on markets in Singapore, Malaysia, and China [6] - The company aims to become a market leader in non-invasive and preventive healthcare, targeting the growing longevity sector to address the healthcare needs of over 1.8 billion people in the region [6] Acquisition Announcement - EUDA has signed a Letter of Intent (LOI) to potentially acquire Chemokine Pte Ltd, a Singapore-based biotech company [1][2] - The exclusivity period for Chemokine is set for at least 120 days, during which it cannot engage in discussions with other entities regarding similar transactions [2] Chemokine Overview - Chemokine specializes in molecular supplements and gene modulating formulations, including a next-generation immune health supplement for which EUDA has obtained exclusive worldwide distribution rights [3] - The company was founded by Professor Kah Meng Lim, a respected molecular medicine researcher with a Ph.D. from the National University of Singapore [4] Product Differentiation - Euda Helixé, the product marketed by EUDA, is designed to support energy, immune resilience, and cellular health, utilizing a unique formulation that includes molecular deer placenta, marine collagen, and bioactive antioxidants [5] - The product employs a gene activation model to modulate gene expression, activating beneficial genes while silencing harmful ones [5]

Company Focus - The company is a dog longevity startup [1] - The company is focused on extending the lifespan of dogs [1] Industry - The article discusses the dog longevity industry [1]

“When we want to live longer, we can all do it together.” @devisridhar tells @alokjha that longevity is related to good policy, and government action. Find out more on “Babbage” https://t.co/FdqtI1eaRd ...

Health & Longevity - The study focuses on "super agers," individuals who maintain good health at 85 years and older [1] - Dr Eric Topol, a 70-year-old cardiologist, shares his personal health tips based on longevity research [1]

RT Matteo Franceschetti (@m_franceschetti)BREAKING: We just raised $100M at @eightsleep to build the AI that finally fixes sleep.For decades, sleep has been passive. You lie down, close your eyes, and hope for the best. We’re changing that.Over 1B hours of biometric sleep data → distilled into fully autonomous AI that knows your body better than you do.We will do this in two ways:Step 1: Your personal Sleep Agent, running infinite nightly scenarios before they happen to deliver the most restorative sleep yo ...

Core Viewpoint - Jupiter Neurosciences, Inc. has announced the addition of Chris Webber as the second brand ambassador for its new longevity supplement line, Nugevia™, which is based on clinical science and innovative performance-driven technology [1][3]. Company Overview - Jupiter Neurosciences is a clinical-stage pharmaceutical company focused on addressing neuroinflammation and promoting healthy aging through a dual-path strategy that includes advancing therapeutics for CNS disorders and entering the consumer longevity market with Nugevia™ [7]. - The company’s proprietary JOTROL™ platform enhances the bioavailability of resveratrol, which is the foundation for both its therapeutic pipeline and the Nugevia™ product line [10]. Product Details - Nugevia™ features three initial formulations—GLO, MND, and PWR—designed to support cellular resilience through synergistic ingredients optimized for absorption via the JOTROL™ system [4]. - The Nugevia™ brand aims to tap into the rapidly growing longevity market, projected to reach $8 trillion by 2030, creating a revenue stream to support ongoing clinical development and enhance long-term shareholder value [5][6]. Scientific Validation - JOTROL™ has demonstrated over nine times higher bioavailability compared to traditional resveratrol products, as evidenced by a Phase I study published in reputable journals [9]. - The technology aims to provide pharmaceutical-grade bioavailability in the wellness space, targeting cognitive health, skin vitality, and cellular energy [10].